← Back to Home

Cardio Diagnostics

Precision cardiovascular medicine company offering AI-driven genetic-epigenetic technology for heart attack risk assessment and disease prevention. Public company (NASDAQ: CDIO).

Company Info

Sector:AI / Machine Learning

Headquarters:United States

Founded:2000

Website:cdio.ai/

Recent News

Clinical Regulatory•Aug 20, 2026•PR Newswire FDA

FDA Clearance of C2N Diagnostics' PrecivityAD2 Blood Test Advances Precision Medicine for Alzheimer's, Building on Groundwork Laid by Early ADDF Investment ↗

FDA Clearance of C2N Diagnostics' PrecivityAD2 Blood Test Advances Precision Medicine for Alzheimer's, Building on Groundwork Laid by Early ADDF Investment

Leadership Team

Careers & Job Openings

See all open roles

All

Multiple